Raval, Jay S.; Padmanabhan, Anand; Kremer Hovinga, Johanna Anna; Kiss, Joseph E. (2015). Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura. American journal of hematology, 90(1), E22-E22. Wiley-Liss 10.1002/ajh.23851
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
PubCrawler_01.10.15.tmp.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (108kB) | Request a copy |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene) |
UniBE Contributor: |
Kremer Hovinga Strebel, Johanna Anna |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0361-8609 |
Publisher: |
Wiley-Liss |
Language: |
English |
Submitter: |
Verena Zwahlen |
Date Deposited: |
07 Mar 2016 10:13 |
Last Modified: |
02 Mar 2023 23:27 |
Publisher DOI: |
10.1002/ajh.23851 |
PubMed ID: |
25219856 |
BORIS DOI: |
10.7892/boris.78696 |
URI: |
https://boris.unibe.ch/id/eprint/78696 |
Actions (login required)
 |
Edit item |